OncoCyte Announces Successful Completion of CLIA Validation Study of the Liquid Biopsy Test DetermaDx™

January 8, 2020 Leave a comment 1,020 Views

OncoCyte Corporation, a developer of novel tests for the early diagnosis and management of lung cancer, today announced the successful completion of the CLIA Validation study of DetermaDx (previously...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: OncoCyte Corporation

OncoCyte Announces Successful Completion of CLIA Validation Study of the Liquid Biopsy Test DetermaDx™

Scientists explain regulation of extracellular vesicles by dephosphorylating Syntenin

Overcoming Chemoresistance via Extracellular Vesicle Inhibition

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Study focuses on a different kind of liquid biopsy to detect cancer

Raman spectral signatures of serum-derived EVs may serve as liquid biopsy for diagnosis of CNS tumors

Extracellular vesicles isolated from milk can improve gut barrier dysfunction induced by malnutrition